世界中医药
文章摘要
引用本文:李妍伸1 李和平2 袁 源2 王建华2 高福生2 张彦周1.通心络胶囊对冠心病心绞痛患者介入治疗后的影响[J].世界中医药,2013,8(10):.  
通心络胶囊对冠心病心绞痛患者介入治疗后的影响
Clinical Observation of Tongxinluo Capsule in Treating Coronary Heart Disease and Angina Pectoris Patient after PCI
投稿时间:2013-09-12  
DOI:10.3969/j.issn.1673-7202.2013.10.042
中文关键词:  通心络胶囊  冠心病心绞痛  介入治疗
English Keywords:Tongxinluo capsule  Angina pectoris of coronary heart disease  Percutaneous coronary intervention
基金项目:
作者单位
李妍伸1 李和平2 袁 源2 王建华2 高福生2 张彦周1 1郑州大学第一附属医院心内科郑州4500522荥阳市人民医院心内科荥阳450100) 
摘要点击次数: 1226
全文下载次数: 1492
中文摘要:
      目的:观察通心络胶囊对冠心病心绞痛患者介入治疗后的影响。方法:将我院收治的240例冠心病心绞痛患者,随机分为治疗组和对照组各120例,两组患者均给予规范西药治疗,治疗组在规范西药治疗基础上加服通心络,治疗时间6个月,观察治疗前后心绞痛疗效、心电图改善、LVEF和6min步行试验变化。结果:治疗6个月后,治疗组心绞痛疗效、心电图疗效、LVEF和6min步行试验明显优于对照组(P<0.05)。结论:冠心病心绞痛患者PCI术后规范西药治疗基础上加用通心络胶囊可获得较好的临床疗效。
English Summary:
      To observe the effects of Tongxinluo capsule on acute myocardial infraction patients of coronary heart disease and angina pectoris patient after PCI. Methods: 240 patients with unstable angina after PCI were randomly divided into treatment group(n=120) and control group (n=120). Two groups were given routine treatment for 6-month treatment, Tongxinluo was added to treatment group. Observation indicator are angina frequent duration time, left ejection fraction(LVEF),ECG results and 6 minute Walk test . Results: After 6 months of treatment, treatment group showed significantly better improvement of all indicators than the control group (P<0.05) . Conclusion:Tongxinluo capsule has good curative effect on angina pectoris of coronary heart disease .
查看全文  查看/发表评论  下载PDF阅读器